Product Design, Manufacturing & Innovation Resources

Últimas publicaciones y patentes sobre medicina regenerativa

Medicina regenerativa

Consejo: además de la selección siguiente, puede buscar y filtrar nuestras 2 bases de datos completas:

> herramienta de búsqueda gratuita de publicaciones < por autor, tema, palabras clave, fecha o revista.

> herramienta de búsqueda gratuita de patentes < para patentes en inglés de la Oficina Europea de Patentes.

Medicina regenerativa
La medicina regenerativa integra la biología de células madre, la ingeniería de tejidos y los biomateriales para innovar en la restauración de tejidos y órganos.

Regenerative medicine focuses on restoring or replacing damaged tissues and organs through the integration of stem cell biology, tissue engineering, and biomaterials science. This interdisciplinary field employs techniques such as scaffold fabrication, cellular reprogramming, and gene editing to promote tissue regeneration, enhance wound healing, and develop functional organ substitutes. Research addresses cellular differentiation, immunomodulation, vascularization, and extracellular matrix remodeling to optimize therapeutic outcomes. Our page compiles the latest peer-reviewed studies and patented tecnologías advancing regenerative strategies, biomaterial innovations, and clinical applications that redefine approaches to tissue repair and organ replacement.

Esta es nuestra última selección de publicaciones y patentes mundiales en inglés sobre Medicina Regenerativa, entre muchas revistas científicas online, clasificadas y centradas en células madre, ingeniería de tejidos, terapia celular, biomateriales, fabricación de andamios, células madre pluripotentes inducidas, andamios regenerativos, matriz extracelular, regeneración de órganos, bioimpresión 3D, factor de crecimiento, célula madre mesenquimal, diferenciación celular, edición genética, cicatrización de heridas, biomaterial regenerativo, trasplante celular, inmunomodulación, regeneración tisular, reprogramación celular, molécula bioactiva, vascularización, terapia regenerativa, célula autóloga, célula alogénica, implante regenerativo, expansión celular, remodelación de la matriz y microambiente regenerativo.

One-pot method for recombinant geranylgeranylated protein production

Patent published on the 2026-06-11 in WO under Ref WO2026122736 by MOZHDEHI DAVOUD [US] (Alam Md Mahbubul [us], Mozhdehi Davoud [us])

Abstract: A method for the one-pot production of geranylgeranylated proteins in Escherichia coli. E. coli is engineered to express geranylgeranyl pyrophosphate synthase, an enzyme that catalyzes production of geranylgeranyl pyrophosphate, and a target protein. By co-expressing GGS with a geranylgeranyltransferase, efficient geranylgeranylation of model protein substrates was achieved, including intrinsically disordered elastin-like polypeptides (ELPs) and the globular protein mCherry. This modification af[...]


Our summary: A one-pot method for producing geranylgeranylated proteins in E. coli was developed. The method involves co-expressing geranylgeranyl pyrophosphate synthase and geranylgeranyltransferase for efficient modification of target proteins. This approach is scalable and cost-effective, enhancing studies on lipid-modified proteins for drug delivery and tissue engineering.

recombinant proteins, geranylgeranylation, Escherichia coli, protein engineering

Patent

Pharmaceutical composition and use thereof, and kit

Patent published on the 2026-06-11 in WO under Ref WO2026119201 by GAN & LEE PHARM CO LTD [CN] (Jiao Jiao [cn], Cui Zhengzhi [cn], Ye Rongcai [cn])

Abstract: Provided are a pharmaceutical composition and a use thereof, and a kit, relating to the technical field of gene therapy. The pharmaceutical composition comprises a recombinant adeno-associated virus (rAAV), a surfactant, and a buffer solution. The rAAV comprises a nucleic acid, and the nucleic acid comprises a coding sequence. The coding sequence is a nucleotide sequence encoding an anti-vascular endothelial growth factor (VEGF) fusion protein or an anti-VEGF antibody. The pharmaceutical composi[...]


Our summary: The pharmaceutical composition includes a recombinant adeno-associated virus with a nucleic acid encoding an anti-VEGF fusion protein. It demonstrates stability and safety, ensuring long-term expression of the exogenous gene. This composition is effective for treating patients with ophthalmic diseases.

gene therapy, recombinant adeno-associated virus, anti-VEGF, ophthalmic diseases

Patent

Lineage-loci engineered cell therapy and related methods of producing and using same

Patent published on the 2026-06-11 in WO under Ref WO2026123001 by UMOJA BIOPHARMA INC [US] (O'hara Samantha [us], Romanov Artem [us], Koning Ryan [us], Vereide David T [us], Yingst Ashley M [us], Jarrell Dillon [us])

Abstract: Provided herein are genetically engineered cells containing a payload in a lineage specific locus and related methods and uses thereof in cell therapy. In some embodiments, the cells are genetically engineered with a CAR, such that expression of the CAR is delayed until the cell is differentiated to a lineage. In some embodiments, the genetically modified cells can be selected for using a selection cassette. Also provided are cell compositions containing the engineered cells, and related methods[...]


Our summary: This content discusses lineage-loci engineered cell therapy and methods for producing genetically engineered cells. It highlights the use of CARs that are expressed upon cell differentiation. Additionally, it covers cell compositions, selection methods, and applications in cancer immunotherapy.

cell therapy, genetically engineered cells, CAR, lineage-specific locus

Patent

Method for preparing porcine induced pluripotent stem cell

Patent published on the 2026-06-11 in US under Ref US20260159814 by SIMPLE PLANET CO LTD [KR] (Han Dongoh [kr], Park Hee Ho [kr], Yoo Ki Hyun [kr], Seo Bong Jong [kr], Jeong Ildoo [kr], Lim Jee Yoon [kr], Kim Kwan Hyun [kr])

Abstract: [0000] The present invention relates to a method for preparing porcine induced pluripotent stem cells (piPSCs), wherein hOCT3, hOCT4, hSK, hUL, mP53DD, and EBNA1 genes are introduced into porcine embryonic fibroblasts by electroporation, thereby producing piPSCs without problems caused by the integration of foreign genes. The porcine induced pluripotent stem cells prepared by the preparation method of the present invention have pluripotency and spontaneous differentiation capability, and in part[...]


Our summary: The invention describes a method for preparing porcine induced pluripotent stem cells (piPSCs) using electroporation to introduce specific genes. This method avoids issues related to foreign gene integration. The resulting piPSCs exhibit pluripotency and strong differentiation potential, particularly towards myotube cells, making them suitable for the cultured meat industry.

induced pluripotent stem cells, porcine, electroporation, differentiation

Patent

Kovacs-like memory effect in strain stiffening collagen networks

Published on 2026-06-10 by Abhishek Ghadai, Maitri Mandal and Sayantan Majumdar @IOP SCIENCE

Abstract: Materials driven far from equilibrium can encode memories of past deformations through long-lived structural reorganizations. Such memory effects-reflecting parameters such as deformation direction, magnitude, and duration have been widely explored in soft amorphous solids. Here, we report a Kovacs-like memory effect manifested as a non-monotonic stress relaxation in vitro biopolymer networks formed by type-I collagen, an essential component of the mammalian extracellular matrix. Using shear rhe[...]


Our summary: The study identifies a Kovacs-like memory effect in type-I collagen networks. This effect is linked to non-monotonic stress relaxation during nonlinear strain-stiffening. The findings reveal a correlation between memory response and negative normal stresses in biopolymer networks.

memory effect, strain stiffening, collagen networks, viscoelasticity

Publication

Computerized method of making a patient-specific orthopedic reconstruction

Patent published on the 2026-06-04 in US under Ref US20260151234 by BLUE SKY TECH LLC [US] (Castro Frank [us])

Abstract: A computerized system and method (123A-C) for the automated design and additive manufacturing of patient-specific orthopedic reconstructions (600R). The method integrates anatomically tagged medical scans, oriented relative to X, Y, and Z axes, with machine-learning models trained on aggregate historical biomechanical outcomes to generate optimized implant geometries. The system calculates an Osseointegration Probability Score (OPS) and a Comprehensive Prognostic Success Score (CPSS) to dynamica[...]


Our summary: The method automates the design and manufacturing of patient-specific orthopedic implants using medical scans and machine-learning models. It calculates scores to optimize implant geometry and internal structures for better stability and reduced complications. The system integrates biomechanical simulations with clinical data for enhanced long-term outcomes.

Orthopedic reconstruction, Additive manufacturing, Machine learning, Biomechanical simulation

Patent

Microcurrent application apparatus for wound healing

Patent published on the 2026-06-04 in US under Ref US20260151619 by BIOLAMP CO LTD [KR] (Seo Minsik [kr], Kim Soyang [kr], Seo Hyukjin [kr], Lee Youngsoon [kr])

Abstract: [0000] Proposed is a microcurrent application apparatus for wound healing. The microcurrent application apparatus includes a healing pad part attached to a wound site, a pH sensor attached to the healing pad part and configured to measure a pH value of the wound site, at least one electrode attached to the healing pad part and configured to apply a microcurrent to the wound site, and a current controller configured to control at least one of polarity and intensity of the microcurrent applied thr[...]


Our summary: The apparatus applies microcurrent to wounds for healing. It includes a pH sensor to measure wound acidity. The current is adjusted based on pH to enhance therapeutic outcomes.

Microcurrent, wound healing, pH sensor, therapeutic effect

Patent

Joint material and shape optimization of a 3D printing nozzle by CFD and response surface methodology

Published on 2026-03-12 by @OXFORD

Abstract: AbstractThree-dimensional printing (3D printing) has emerged as a transformative technology in medicine, enabling the fabrication of complex structures with high precision. In bioprinting, optimization of nozzle design is essential to balance print resolution, mechanical strength, and biocompatibility. This study presents a computational framework for optimizing bioprinting performance by simultaneously accounting for nozzle geometry and biomaterial rheological properties. Using computational fl[...]


Our summary: This study presents a computational framework for optimizing bioprinting by integrating nozzle geometry and biomaterial properties. It utilizes CFD and response surface methodology to identify optimal nozzle configurations. Results show significant improvements in flow rate and reductions in wall shear stress, demonstrating the effectiveness of the approach.

3D printing, nozzle optimization, computational fluid dynamics, response surface methodology

Publication

Temas tratados: Medicina regenerativa, biología de células madre, ingeniería de tejidos, biomateriales, fabricación de andamios, reprogramación celular, edición de genes, regeneración de tejidos, cicatrización de heridas, sustitutos de órganos, diferenciación celular, inmunomodulación, vascularización, remodelación de la matriz extracelular, resultados terapéuticos, estudios revisados por expertos, aplicaciones clínicas, ISO 13485, ISO 14971, ASTM F2633, ISO 10993 e ISO 14644.

Contexto histórico

1965
1970
1980
1980
1990
1960
1969
1976-05-28
1980
1990

(Si la fecha es desconocida o no es relevante, por ejemplo "mecánica de fluidos", se proporciona una estimación redondeada de su aparición notable)

Las imágenes a tamaño completo y las descargas sólo están disponibles, 100% gratis, para los miembros registrados.

> Acceso <